Journal
Papers, Abstracts,
and Commentaries
| |
Immunologic and Virologic Mechanisms for Partial Protection
from Intravenous Challenge by an Integration-Defective SIV Vaccine.
Wang C, Jiang C, Gao N,
Viruses.
2017 Jun 2;9(6). \
Abstract
FULL-TEXT
ARTICLE
Harm
reduction interventions in HIV care: a qualitative exploration of patient
and provider perspectives.
Carlberg-Racich S.
PeerJ. 2016 Apr 14;4:e1932r
14;4:e1932
Paper
FULL-TEXT ARTICLE
Correlates of
public support toward federal funding for harm reduction strategies.
Kulesza M, Teachman BA, Werntz AJ,
et al
Subst Abuse Treat Prev Policy.
2015 Jun 30;
Paper
Examining the potential role of a supervised injection
facility in Saskatoon, Saskatchewan, to avert HIV among people who
inject drugs.
Jozaghi E, Jackson A.
Int J Health Policy Manag.
2015 Mar 29;4(6):373-379
Abstract
How far will they go?: assessing the travel distance of
current and former drug users to access harm reduction services.
Allen S, Ruiz M, O'Rourke A.
Harm Reduct J. 2015 Mar 1;12(1):3.
Abstract
FULL-TEXT
DOCUMENT
Cost-Effectiveness Analysis of Brief and Expanded Evidence-Based Risk Reduction
Interventions for HIV-Infected People Who Inject Drugs in the United States.
Song DL, Altice FL, Copenhaver MM, Long EF.
PLoS One. 2015 Feb
6;10(2):e0116694.
Paper
Novel Interventions to Prevent HIV and HCV Among Persons Who
Inject Drugs.
Coffin PO, Rowe C, Santos GM.
Curr HIV/AIDS Rep.
2015 Jan 15.
Abstract
Trends in use of health care and HIV prevention services
for persons who inject drugs in San Francisco: Results from National HIV
Behavioral Surveillance 2005-2012.
Coffin PO, Jin H, Huriaux E, et al
Drug Alcohol Depend. 2014
Nov 6. pii: S0376-8716(14)01888-2.
Abstract
Injection Drug Users' Perceived Barriers to Using Self-Initiated
Harm Reduction Strategies.
Bonar EE, Rosenberg H.
Addict Res Theory. 2014 Aug
1;22(4):271-278.
Abstract
FULL TEXT ARTICLE
Transitions in Latent Classes of Sexual Risk Behavior Among Young Injection Drug
Users Following HIV Prevention Intervention.
Mackesy-Amiti ME, Ouellet LJ, Finnegan L, et al
AIDS Behav.
2014 Mar;18(3):464-72.
Paper
Combined HIV Prevention, the New York City Condom
Distribution Program, and the Evolution of Safer Sex Behavior Among Persons
Who Inject Drugs in New York City.
Des Jarlais DC, Arasteh K, McKnight C, et al
AIDS Behav. 2013 Nov 24.
Abstract
Transitions in Latent Classes of Sexual Risk Behavior Among
Young Injection Drug Users Following HIV Prevention Intervention.
Mackesy-Amiti ME, Ouellet LJ, Finnegan L, et al
AIDS Behav. 2013 Aug 22
Abstract
Not just the needle: the state of HIV-prevention science
among substance users and future directions.
Shoptaw S, Montgomery B, Williams CT, et al
J Acquir Immune Defic Syndr.
2013 Jul;63 Suppl 2:S174-8
Abstract
Development of a Risk Reduction Intervention to Reduce Bacterial
and Viral Infections for Injection Drug Users.
Phillips KT, Altman JK, Corsi KF, Stein MD.
Subst Use Misuse. 2012 Sep 27
Abstract
Differing HIV Risks and Prevention Needs among Men and Women Injection Drug
Users (IDU) in the
District of Columbia
Magnus M, Kuo I, Phillips G 2nd, Rawls A, et al
J Urban Health. 2012 Jun 13.
Abstract
Skin and needle hygiene intervention for injection drug users:
Results from a randomized, controlled Stage I
pilot trial.
Phillips KT, Stein MD, Anderson BJ, Corsi KF.
J Subst Abuse Treat. 2012 Feb 14.
Abstract |
Injection Drug Users' Perspectives on Placing HIV Prevention and Other Clinical
Services in
Pharmacy Settings.
Lutnick A, Case P, Kral AH.
J Urban Health. 2012 Jan 10.
Abstract
Attitudes of methadone program staff toward provision of harm-reduction and
other services.
Deren S, Kang SY, Mino M, Seewald RM.
J Addict Med. 2011
Dec;5(4):289-92.
Abstract
Potential role of safer injection facilities in reducing HIV and
Hepatitis C infections and
overdose mortality in the United States.
Semaan S, Fleming P, Worrell C,
et al
Drug Alcohol Depend.
2011 Apr 22
Abstract
Injection risk behaviors among rural drug users: implications
for HIV prevention.
Havens JR, Oser CB, Leukefeld CG.
AIDS Care.
2011 May;23(5):638-45
Abstract
Harm Reduction and 12 Steps: Complementary, Oppositional, or
Something In-Between?
Lee HS, Engstrom M, Petersen SR.
Subst Use Misuse. 2011 Mar 11
Abstract
Symbiotic goals and the prevention of blood-borne viruses among
injection drug users.
Friedman SR, Sandoval M, Mateu-Gelabert P, et al
Subst Use Misuse.
2011;46(2-3):307-15.
Abstract |
|
|
|
|
Conference Reports, Abstracts, and Posters
Journal Papers, Abstracts,
and Commentaries
Journal Papers, Abstracts,
and Commentaries
General/Miscellaneous Reports
Journal Papers, Abstracts,
and Commentaries
Syringe Disinfection
Journal Papers, Abstracts,
and Commentaries
Syringe/Needle Provision/Exchange
Journal Papers, Abstracts,
and Commentaries
| |
|
The Significance of Harm Reduction as a Social and Health
Care Intervention for Injecting Drug Users: An Exploratory Study of a
Needle Exchange Program in Fresno, California.
Clarke K, Harris D, Zweifler JA,
et al
Soc Work Public Health.
2016 Aug-Sep;31(5):398-407
Abstract
The Significance of Harm Reduction as a Social and Health Care Intervention
for Injecting Drug Users: An Exploratory Study of a Needle Exchange Program
in Fresno, California.
Clarke K, Harris D, Zweifler JA,
et al
Soc Work Public Health.
2016 May 11:1-10.
Abstract
Trend
Analyses of
Users of a
Syringe
Exchange
Program in
Philadelphia,
Pennsylvania:
1999-2014.
Maurer LA,
Bass SB, Ye
D, et al
AIDS Behav.
2016 Apr 11.
Abstract
Assessing
Syringe
Exchange
Program
Access among
Persons Who
Inject Drugs
(PWID) in
the District
of Columbia.
Allen ST,
Ruiz MS,
Jones J.
J Urban
Health.
2016 Jan 19.
Abstract
Pharmacy-randomized
intervention
delivering
HIV
prevention
services
during the
syringe sale
to people
who inject
drugs in New
York City.
Lewis CF,
Rivera AV,
Crawford ND,
et al
Drug Alcohol
Depend.
2015 Jun 10.
Abstract
FULL-TEXT ARTICLE
The evidence
does not
speak for
itself: The
role of
research
evidence in
shaping
policy
change for
the
implementation
of publicly
funded
syringe
exchange
programs in
three US
cities.
Allen ST,
Ruiz MS,
O'Rourke A.
Int J Drug
Policy.
2015
Jul;26(7):688-695.
Paper
Consequences
of a
restrictive
syringe
exchange
policy on
utilisation
patterns of
a syringe
exchange
program in
Baltimore,
Maryland:
Implications
for
HIV
risk.
Sherman SG,
Patel SA,
Ramachandran
DV, et
al
Drug Alcohol
Rev.
2015 Apr 28
Abstract
Evidence-Based Policy Versus Morality Policy: The Case of
Syringe Access Programs.
de Saxe Zerden L, O'Quinn E, Davis C.
J Evid Inf Soc Work. 2015 Mar
6:1-13.
Abstract
Hepatitis C Prevention and Needle Exchange Programs in Rhode
Island: ENCORE.
Joseph R, Kofman A, Larney S, Fitzgerald P.
R I Med J (2013). 2014 Jul 1;96(7):31-4.
Abstract
Community Impact of Pharmacy-Randomized Intervention to
Improve Access to Syringes and Services for Injection Drug Users.
Crawford ND, Amesty S, Rivera AV et al
Health Educ Behav. 2014 Apr 10.
Abstract
Integrating health and prevention services in syringe access
programs: a strategy to address unmet needs in a high-risk population.
Burr CK, Storm DS, Hoyt MJ, et al
Public Health Rep. 2014 Jan;129
Suppl 1:26-32
Abstract
Beyond NIMBYism: Understanding community antipathy toward
needle distribution services.
Davidson PJ, Howe M.
Int J Drug Policy.
2013 Nov 7.
Abstract
Contraception and Clean Needles: Feasibility of Combining Mobile
Reproductive Health and Needle Exchange Services for Female Exotic Dancers.
Moore E, Han J, Serio-Chapman C,
et al
Am J Public Health. 2012 Aug
16.
Abstract
Prospective effects of traumatic event re-exposure and PTSD in
syringe exchange participants.
Peirce JM, Brooner RK, Kolodner K,
Addiction. 2012 Jul 6.
Abstract
Spatial Access to Sterile Syringes and the Odds of Injecting with an Unsterile
Syringe among Injectors:
A
Longitudinal Multilevel Study.
Cooper H, Des Jarlais D, Ross Z,
et
al
J Urban Health. 2012 May 15.
Abstract
|
Pharmacist and Pharmacy Staff Experiences with Non-prescription (NP)
Sale of Syringes and Attitudes Toward Providing HIV Prevention Services
for Injection Drug Users (IDUs) in Providence, RI.
Zaller N, Jeronimo A, Bratberg J, et al
J Urban Health. 2010 Nov 30.
Abstract |
FULL-TEXT ARTICLE
Syringe Exchange Programs --- United States, 2008.
Centers for Disease Control and Prevention (CDC).
MMWR Morb Mortal Wkly Rep. 2010 Nov
19;59(45):1488-1491.
Paper |
Adverse event associated with a change in nonprescription
syringe sale policy.
Zaller ND, Yokell MA, Jeronimo A,
et al
J Am Pharm Assoc (2003).
2010 Sep-Oct;50(5):619-22
Abstract
|
Evaluation of nonprescription syringe sales in San Francisco.
Rose VJ, Raymond HF.
J Am Pharm Assoc (2003). 2010
Sep-Oct;50(5):595-9.
Abstract |
Pharmacy Participation in Non-Prescription Syringe Sales in Los Angeles and
San FranciscoCounties, 2007.
Cooper EN, Dodson C, Stopka TJ,
et al
J Urban Health. 2010 Jun 12
Abstract |
A community-based approach to linking injection drug users with needed services
through
pharmacies: an evaluation of a pilot intervention in New York City.
Rudolph AE, Standish K, Amesty S, et al
AIDS Educ Prev. 2010 Jun;22(3):238-5
Abstract |
Three Years after Legalization of Nonprescription Pharmacy
Syringe Sales in California:
Where Are We Now?
Garfein RS, Stopka TJ, Pavlinac PB, et al
J Urban Health. 2010 Jun 10.
Abstract |
Access to Sterile Syringes through San Francisco Pharmacies and the Association
with HIV Risk Behavior among Injection Drug Users.
Riley ED, Kral AH, Stopka TJ, et al
J Urban Health. 2010 Jun 5.
Abstract |
FULL-TEXT PDF ARTICLE
Lessons learned from a peri-urban needle exchange.
Knittel AK, Wren PA, Gore L.
Harm Reduct J. 2010 Apr
29;7(1):8
Paper |
|
|
| |
|
|
|
|
|
|
|
|
|
Conference Reports, Abstracts, and Posters
|
| |
|
|
General/Miscellaneous
Reports
IDU Main Page
Documents identified with this icon are in Portable Document Format (PDF)
and require the
Adobe
Acrobat Reader